Thomas Breuer and colleagues at GlaxoSmithKline respond to Peter Doshi.
| Autor: | Breuer T; GSK Vaccines, 20 Avenue Fleming, 1300 Wavre, Belgium., Bauchau V; GSK Vaccines, 20 Avenue Fleming, 1300 Wavre, Belgium., Poplazarova T; GSK Vaccines, 20 Avenue Fleming, 1300 Wavre, Belgium., Stegmann JU; GSK Vaccines, 20 Avenue Fleming, 1300 Wavre, Belgium. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | BMJ (Clinical research ed.) [BMJ] 2018 Oct 03; Vol. 363, pp. k4116. Date of Electronic Publication: 2018 Oct 03. |
| DOI: | 10.1136/bmj.k4116 |
| Abstrakt: | Competing Interests: Competing interests: TB, VB, TP, J-US are employed by and hold shares in the GlaxoSmithKline group of companies. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|